Hepatitis C treatment outcomes of African Americans following liver transplantation

Transplantation Proceedings

Volumn 34, Issue 8, 2002, Pages 3317-3318

  Smallwood, Greg A ^a   Coffey, G ^a   Davis, L ^a   Martinez, E ^a   Stieber, A C ^a   Heffron, T G ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; AGE; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENDER; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL; RACE; RECURRENT DISEASE; SURVIVAL RATE; AFRICAN AMERICAN; FEMALE; GENOTYPE; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

AFRICAN AMERICANS; FEMALE; GENOTYPE; GEORGIA; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036903557     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03573-X     Document Type: Article

References (3)

1. Detre K., Belle S., Lombardero M. Viral Hepatol. 29:1999;250.
2. Hepatology. 26:(suppl 1):1997;25.
3. Howell C., Jeffers L., Hoofnagle J. Gastroenterology. 119:2000;1385.